- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on May 5, 2021 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| May 6, 2021 | A-431-19 | APP | Pfizer Canada Ulc V. Seedlings Life Science Ventures, Llc (Patent) | Ottawa | 1 d |
| May 6, 2021 | A-44-20 | APP | Seedlings Life Science Ventures, Llc V. Pfizer Canada Ulc/pfizer Canada Sri (unknown) | Ottawa | 1 d |
| May 6, 2021 | T-451-20 | CMC | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 1 h |
| May 7, 2021 | T-1590-19 | CMC | 6571531 Canada Inc. Et Al. V. 2413998 Ontario Inc. (Trade Mark) | Ottawa | 1 h |
| May 11, 2021 | T-124-21 | CMC | Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 30 m |
| May 11, 2021 | T-1480-19 | MSC | Alliance Nationale De L'industrie Musicale C. Conseil De La Radiodiffusion (Copyright) | Montréal | 4 h |
| May 11, 2021 | T-1138-20 | CMC | Outpost Productions, Inc. V. Doe # 1 Et Al (Copyright) | Toronto | 30 m |
| May 11, 2021 | T-198-20 | CMC | Fallen Productions, Inc. V. Doe #1 Et Al (Copyright) | Toronto | 30 m |
| May 11, 2021 | T-89-18 | TMC | Mud Engineering Inc. V. Secure Energy Services Inc. Et Al (Patent) | Toronto | 1 h |
| May 12, 2021 | T-1252-19 | CMC | Modpro Containers Ltd Et Al. V. Tangle Pools Et Al. (unknown) | Vancouver | 1 h |
| May 12, 2021 | T-1209-20 | M | Dermaspark Products Inc. Et Al. V. Skintegrity Cosmedical Laser Skin Et Al. (Copyright) | Ottawa | 2 h |
| May 12, 2021 | T-1268-20 | CMC | Janssen Inc. Et Al. V. Sandoz Canada Inc (Patent - Canagliflozin*) | Toronto | 1 h |
| May 12, 2021 | T-1642-16 | TMC | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Ottawa | 1 h |
| May 12, 2021 | T-1662-17 | MED | Crocs Canada, Inc. And Crocs Inc. V. Double Diamond Distribution Ltd. (Trade Mark) | Ottawa | 1 d |
| May 12, 2021 | T-418-20 | CMC | Merck Sharp & Dohme Corp Et Al. V. Sandoz Canada Inc (Patent - Sitagliptin*) | Toronto | 1 h |
| May 12, 2021 | T-419-20 | CMC | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 1 h |
| May 12, 2021 | T-419-20 | CMC | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 30 m |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Jun 14, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 13 d |
| Jul 5, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 2 d |
| Jul 19, 2021 | T-1642-16 | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Calgary | 10 d |
| Jul 19, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 5 d |
| Aug 3, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 4 d |
| Sep 1, 2021 | T-2072-19 | Boehringer Ingelheim (canada) Ltd. Et Al V. Teva Canada Limited (Patent - Aftinib*) | Toronto | 11 d |
| Oct 4, 2021 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 16 d |
| Oct 18, 2021 | T-34-20 | Amgen Inc. Et Al V. Purdue Pharma (Patent - Pegfilgrastim*) | Toronto | 10 d |
| Oct 25, 2021 | T-1606-18 | Richards Packaging Inc. V. Distrimedic Inc (Patent) | Montréal | 15 d |
| Oct 28, 2021 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 2 d |
| Nov 1, 2021 | T-315-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| Nov 15, 2021 | T-353-20 | Celgene Inc. Et Al V. Natco Pharma (canada)inc. (Patent - Pomalidomide*) | Toronto | 15 d |
| Nov 15, 2021 | T-815-17 | Pharmascience Inc. V. Meda Ab Et Al (PMNOC - Section 8 - Zolpidem*) | Montréal | 8 d |
| Nov 15, 2021 | T-327-19 | Paypal, Inc. V. One 97 Communications Ltd. Et Al (Trade Mark) | Toronto | 12 d |
| Nov 16, 2021 | T-347-20 | Eisai Limited Et Al V. Taro Pharmaceuticals Inc. (Patent - Perampanel*) | Toronto | 11 d |
| Dec 2, 2021 | T-418-20 | Merck Sharp & Dohme Corp Et Al. V. Sandoz Canada Inc (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 2, 2021 | T-419-20 | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 6, 2021 | T-270-20 | Bayer Inc. Et Al V. Pharmascience Inc. (Patent) | Ottawa | 10 d |
| Jan 10, 2022 | T-1591-15 | Energizer Brands, Llc Et Al. V. The Gillette Company Et Al (Trade Mark) | Toronto | 10 d |
| Jan 10, 2022 | T-1420-18 | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 20 d |
| Jan 10, 2022 | T-567-20 | Ncs Multistage Inc. V. Promac Industries Ltd. (Patent) | Calgary | 20 d |
| Jan 17, 2022 | T-827-20 | Viiv Healthcare Company, Shionogi & Co., Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Dolutegravir*) | Toronto | 10 d |
| Jan 17, 2022 | T-1660-11 | Bernard Charles Sherman Et Al V. Pfizer Canada Inc., Et Al (Patent - Quinapril*) | Toronto | 10 d |
| Jan 24, 2022 | T-549-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 7 d |
| Feb 7, 2022 | T-555-20 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Apixaban*) | Toronto | 5 d |
| Feb 14, 2022 | T-1935-13 | Bernard Charles Sherman Et Al V. Pharmascience Inc (Patent - Quinapril*) | Toronto | 10 d |
| Feb 14, 2022 | T-1420-18 | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 2 d |
| Feb 14, 2022 | T-567-20 | Ncs Multistage Inc. V. Promac Industries Ltd. (Patent) | Calgary | 2 d |
| Feb 14, 2022 | T-1066-17 | T-rex Property Ab V. Pattison Outdoor Advertising Limited Partnership Et Al (Patent) | Toronto | 15 d |
| Feb 28, 2022 | T-665-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-666-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-563-20 | Merck Sharp & Dohme Corp. Et Al V Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-561-20 | Merck Sharp & Dohme Corp. Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-560-20 | Merck Sharp& Dohme Corp Et Al V. Apotex Inc (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 14, 2022 | T-1769-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 24 d |
| Mar 14, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 24 d |
| Mar 21, 2022 | T-1861-17 | Denis Cimaf Inc. C. Fecon Inc. (Trade Mark) | Ottawa | 10 d |
| Mar 28, 2022 | T-667-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 28, 2022 | T-798-20 | Opiant Pharmaceuticals Inc. Et Al V. Teva Canada Ltd. (Patent - Naloxone*) | Toronto | 10 d |
| Mar 28, 2022 | T-1187-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Apr 4, 2022 | T-769-20 | Janssen Inc. Et Al. V. Jamp Pharma Corporation (Patent - Macitentan*) | Toronto | 10 d |
| Apr 25, 2022 | T-671-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| May 30, 2022 | T-1581-20 | Celgene Inc. Et Al V. Natco Pharma (canada) Inc. (Patent - Pomalidomide*) | Toronto | 7 d |
| May 30, 2022 | T-2009-19 | Samsung Bioepis Co.,ltd. V. Fresenius Kabi Deutschlandf Gmbh (Patent - Adalimumab*) | Toronto | 10 d |
| Jun 6, 2022 | T-13-20 | Andritz Ltd Et Al. V. Cortex North America Corporation (Patent) | Montréal | 12 d |
| Jun 6, 2022 | T-891-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Jamp Pharma Corporation (Patent - Lurasidone*) | Toronto | 10 d |
| Jun 13, 2022 | T-952-20 | Google Llc V. Sonos, Inc. (Patent) | Toronto | 10 d |
| Jul 4, 2022 | T-1441-20 | Janssen Inc. Et Al V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Jul 4, 2022 | T-601-20 | Merck Sharp & Dohme Corp Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-602-20 | Merck Sharp & Dohme Corp. Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-668-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-670-20 | Merck Sharp & Dohme Corp, Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-673-20 | Merck Sharp & Dohme Corp. Et Al V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 5, 2022 | T-1207-20 | Pfizer Canada Ulc Et Al. V. Jamp Pharma Corporation (Patent - Tofacitinib*) | Toronto | 9 d |
| Aug 2, 2022 | T-1268-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc (Patent - Canagliflozin*) | Toronto | 10 d |
| Aug 15, 2022 | T-1467-20 | Celgene Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lenalidomide*) | Toronto | 15 d |
| Sep 12, 2022 | T-16-21 | Boehringer Ingelheim (canada)ltd. Et Al V. Sandoz Canada Inc. (Patent - Linagliptin*) | Toronto | 15 d |
| Sep 26, 2022 | T-124-21 | Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Oct 17, 2022 | T-6-21 | Merck Sharp & Dohme Corp. Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 7 d |
| Oct 17, 2022 | T-415-21 | Merck Sharp & Dohme Corp. Et Al V. Sandoz Canada Inc. (Copyright - Sitagliptin*) | Toronto | 7 d |
| Nov 14, 2022 | T-1531-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-380-21 | Biomarin Pharmaceutical Inc. V. Dr. Reddy's Laboratories Ltd. (Patent - Sapropterin*) | Toronto | 10 d |
| Nov 14, 2022 | T-1533-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Dec 5, 2022 | T-373-21 | Bristol-myers Squibb Canada Co Et Al V. Sun Pharma Canada Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Dec 5, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 10 d |
| Jan 9, 2023 | T-1007-20 | Medexus Pharmaceuticals Inc. Et Al. V. Accord Healthcare Inc. (Patent) | Ottawa | 14 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Jun 2, 2021 | T-1471-19 | Merck Canada Inc. V. The Minister Of Health - Suvorexant* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Jun 22, 2021 | T-1180-20 | Norsteel Building Systems Ltd. V. Toti Holdings Inc. | Trade Mark Expungement | Vancouver | 1 d |
| Jun 23, 2021 | T-12-20 | H & R Import-export Inc V. Tabesh Global Export Inc Et Al | S. 18.1 Application for Judicial Review | Toronto | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| May 6, 2021 | A-431-19 | Pfizer Canada Ulc V. Seedlings Life Science Ventures, Llc | Appeal (S.27 - Interloc.) - Patent Act [from T-608-17 - Patent Infringement] | Ottawa | 1 d |
| May 6, 2021 | A-44-20 | Seedlings Life Science Ventures, Llc V. Pfizer Canada Ulc/pfizer Canada Sri | Appeal (S.27 - Final) - Others | Ottawa | 1 d |
| Jun 8, 2021 | A-143-20 | Bauer Hockey Ltd. V. Sport Maska Inc. D.b.a. Ccm Hockey | Appeal (S.27 - Final) - Patent Act [from T-546-12 - Patent Infringement] | Ottawa | 4 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.